Healthcare Infection Control Practices Advisory Committee (HICPAC); Correction, 28834 [2021-11379]
Download as PDF
<![CDATA[
28834
Federal Register / Vol. 86, No. 102 / Friday, May 28, 2021 / Notices
• Motion to Adjourn
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[FR Doc. 2021–11312 Filed 5–27–21; 8:45 am]
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 6820–95–P
[FR Doc. 2021–11379 Filed 5–27–21; 8:45 am]
David Coscia,
Agency Liaison Officer, Office of Presidential
& Congressional Agency Liaison Services,
General Services Administration.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC);
Correction
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP, STAC); Notice of
Charter Renewal
Notice is hereby given of a change in
the meeting of the Healthcare Infection
Control Practices Advisory Committee
(HICPAC); June 3, 2021, from 9 a.m. to
3 p.m., EDT in the original FRN.
The teleconference was published in
the Federal Register on April 9, 2021,
Volume 86, Number 67, page 18533.
The teleconference meeting is being
corrected to update the time and should
read as follows:
SUMMARY: In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by audio and
web conference lines (300 audio and
web conference lines are available).
Registration is required. To register for
this web conference, please go to:
www.cdc.gov/hicpac. All registered
participants will receive the meeting
link and instructions shortly before the
meeting.
DATES: The meeting will be held on June
3, 2021, from 12 p.m. to 3 p.m., EDT.
This meeting is open to the public.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, CDC, 1600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027, Telephone: (404) 498–
0730; Email: HICPAC@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
17:28 May 27, 2021
Jkt 253001
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of charter renewal.
This gives notice that under
Public Law 111–347 (the James Zadroga
9/11 Health and Compensation Act of
2010), as amended by Public Law 114–
113, and the Federal Advisory
Committee Act (Pub. L. 92–463) of
October 6, 1972, the World Trade Center
Health Program Scientific/Technical
Advisory Committee, the Centers for
Disease Control and Prevention,
Department of Health and Human
Services, has been renewed for a 2-year
period through May 12, 2023.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D.,
Designated Federal Officer, WTCHP
STAC, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE,
Mailstop R–12, Atlanta, GA 30329–
4027, Telephone: (513) 841–4515;
Email: TCarreonValencia@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–11378 Filed 5–27–21; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
[30Day–21–21CT]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
submitted the information collection
request titled ‘‘Requirement for Negative
Pre-Departure Covid–19 Test Result or
Documentation of Recovery From
Covid–19 for all Airline or other Aircraft
Passengers Arriving into the United
States from any Foreign Country’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on February 12, 2021 to obtain
comments from the public and affected
agencies. This collection accompanies a
CDC Order of the same name. CDC
received two comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
E:\FR\FM\28MYN1.SGM
28MYN1
]]>Agencies
[Federal Register Volume 86, Number 102 (Friday, May 28, 2021)]
[Notices]
[Page 28834]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11379]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC); Correction
Notice is hereby given of a change in the meeting of the Healthcare
Infection Control Practices Advisory Committee (HICPAC); June 3, 2021,
from 9 a.m. to 3 p.m., EDT in the original FRN.
The teleconference was published in the Federal Register on April
9, 2021, Volume 86, Number 67, page 18533.
The teleconference meeting is being corrected to update the time
and should read as follows:
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This virtual meeting is open to
the public, limited only by audio and web conference lines (300 audio
and web conference lines are available). Registration is required. To
register for this web conference, please go to: www.cdc.gov/hicpac. All
registered participants will receive the meeting link and instructions
shortly before the meeting.
DATES: The meeting will be held on June 3, 2021, from 12 p.m. to 3
p.m., EDT.
This meeting is open to the public.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, National Center for Emerging
and Zoonotic Infectious Diseases, CDC, 1600 Clifton Road NE, Mailstop
H16-3, Atlanta, Georgia 30329-4027, Telephone: (404) 498-0730; Email:
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-11379 Filed 5-27-21; 8:45 am]
BILLING CODE 4163-18-P
